Newly Released Video: ILPMP Overview

ILPMP / PMPnow Directors Attend National Assocation of State Controlled Substance Authorities Conference

Sarah Pointer, ILPMP Clinical Director (Right) and Jennifer Erickson, PMPnow Director (Left), attended the National Association of State Controlled Substances Authorities Conference (NASCSA) that took place October 23 -26, 2023 in Minneapolis, Minnesota.

The purpose of the National Association of State Controlled Substances Authorities is to provide a forum for the discussion and exchange of information and ideas, to develop, implement and monitor ongoing strategies and to curtail the abuse, misuse and diversion of controlled substances.

ILPMP Upcoming Conference Schedule

November

Nurse Practitioner Week Illinois Conference

November 18

Georgios Banquet Hall, 8800 W 159th Street

Orland Park, IL

Eric Huff, ILPMP Clinical Project Manager, (pictured above) and Jackie DeNardo, PMPnow Coordinator, (not pictured) represented the ILPMP booth on November 18th at the Nurse Practitioner Week Illinois Conference in Orland Park, IL.

Legislation Update

Public Act 103-0425

Exemptions/Waivers to E-Prescribing Mandate – All healthcare professionals who write prescriptions for controlled substances must, on January 1, 2024, provide those prescriptions electronically.

See Exemptions/Waivers

Public Act 102-1038

No individual or group policy of accident and health insurance amended, delivered, issued, or renewed after January 1, 2024, that provides coverage for naloxone hydrochloride shall impose a copayment on the coverage provided, except that this subsection does not apply to coverage of naloxone hydrochloride to the extent such coverage would disqualify a high-deductible health plan from eligibility for a health savings account under Section 223 of the Internal Revenue Code.

Educational Resources

NEW Webinar: Continuing Medical Education

Benefits of a Designee

Webinar

Describe the ILPMP program and registration process

Explain how a prescriber can assign a designee

Identify the capabilities and responsibilities of a prescriber and designee within the ILPMP

Discuss the importance and benefits of assigning designee(s)

1.0 contact hour CME

Data Quality in Prescription Monitoring Programs

Take advantage of this FREE ACPE accredited educational opportunity providing 1 hour of continuing education for pharmacists and pharmacy technicians. This continuing education activity will provide insight into how pharmacy's data entry process affects prescription monitoring program data, clinical decision making, and downstream data analysis.

More Information

Navigating Pain Management, Safe Opioid Prescribing, and Opioid Use Disorder

A three-hour CE program designed to meet the educational needs for pharmacists. The program will be accredited in 6, 30-minute modules/sessions.

To Register

ILPMP.ORG & PMPnow Monthly Data

Contact Information

If you have questions about the information that appears in this update or suggestions for future content, please email dhs.pmp@illinois.gov. Visit www.ilpmp.org for more information.

The Illinois Prescription Monitoring Program (ILPMP) is an electronic database that collects, tracks, and stores reported dispensing data on Schedule II-V controlled substances, selected drugs of interest, and other health information. The Illinois Department of Human Services oversees the ILPMP, authorized by the Illinois Controlled Substances Act (720 ILCS 570/316). The ILPMP adheres to HIPAA and all access, disclosure, and confidentiality provisions of Illinois Law.